These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31686128)

  • 1. Characterization and validation of a novel measure of septic shock severity.
    Bosch NA; Teja B; Wunsch H; Walkey AJ
    Intensive Care Med; 2020 Jan; 46(1):135-137. PubMed ID: 31686128
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature.
    Leone M; Asfar P; Radermacher P; Vincent JL; Martin C
    Crit Care; 2015 Mar; 19(1):101. PubMed ID: 25888071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy.
    Kim WY; Jun JH; Huh JW; Hong SB; Lim CM; Koh Y
    Shock; 2013 Dec; 40(6):527-31. PubMed ID: 24089010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-size MAP does not fit all.
    Senussi MH
    Crit Care; 2015 May; 19(1):212. PubMed ID: 25947571
    [No Abstract]   [Full Text] [Related]  

  • 5. Initial Arterial Blood Pressure Targets in Patients With Septic Shock: One Size Fits All or Made to Measure?
    Jörres A
    Crit Care Med; 2021 Apr; 49(4):719-721. PubMed ID: 33731615
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose vasopressin for reversing vasodilation during septic shock.
    Gazmuri RJ; Shakeri SA
    Crit Care Med; 2001 Mar; 29(3):673-5. PubMed ID: 11373445
    [No Abstract]   [Full Text] [Related]  

  • 7. A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study.
    Xu JY; Ma SQ; Pan C; He HL; Cai SX; Hu SL; Liu AR; Liu L; Huang YZ; Guo FM; Yang Y; Qiu HB
    Crit Care; 2015 Mar; 19(1):130. PubMed ID: 25887027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
    Vadiei N; Daley MJ; Murthy MS; Shuman CS
    Ann Pharmacother; 2017 Mar; 51(3):194-202. PubMed ID: 27886982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW
    Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine in septic shock.
    Hernández G; Teboul JL; Bakker J
    Intensive Care Med; 2019 May; 45(5):687-689. PubMed ID: 30631902
    [No Abstract]   [Full Text] [Related]  

  • 11. Should all patients with septic shock have a mean arterial pressure threshold of 65 mmHg?
    Campbell N; McGuire S; Carle C
    Br J Hosp Med (Lond); 2020 Sep; 81(9):1-2. PubMed ID: 32990072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine Dosing in Obese and Nonobese Patients With Septic Shock.
    Radosevich JJ; Patanwala AE; Erstad BL
    Am J Crit Care; 2016 Jan; 25(1):27-32. PubMed ID: 26724290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy?
    Levy JH; Ghadimi K; Faraoni D; van Diepen S; Levy B; Hotchkiss R; Connors JM; Iba T; Warkentin TE
    J Thromb Haemost; 2019 Nov; 17(11):1973-1978. PubMed ID: 31334603
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.
    Hammond DA; Cullen J; Painter JT; McCain K; Clem OA; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019; 34(11-12):910-916. PubMed ID: 28820036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin in critical illness: sometimes even old players leave a lot to discover. Preface.
    Westphal M; Ertmer C
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):vii-ix. PubMed ID: 18683470
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB; Ashton RC; Landry DW; Townsend RN
    J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic arterial elastance predicts mean arterial pressure decrease associated with decreasing norepinephrine dosage in septic shock.
    Guinot PG; Bernard E; Levrard M; Dupont H; Lorne E
    Crit Care; 2015 Jan; 19(1):14. PubMed ID: 25598221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory septic shock: our pragmatic approach.
    Nandhabalan P; Ioannou N; Meadows C; Wyncoll D
    Crit Care; 2018 Sep; 22(1):215. PubMed ID: 30231909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.
    Lee CS
    Crit Care Nurse; 2006 Dec; 26(6):17-23. PubMed ID: 17123948
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
    Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
    Trials; 2016 Aug; 17():384. PubMed ID: 27484695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.